# BioLife Solutions, Inc. (BLFS) FY2026 Q2 P&L / Income Statement

- Company: BioLife Solutions, Inc. (BLFS)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001628280-26-054355
- Page: https://plicit.ai/financials/blfs/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/blfs-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Geography

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 28,466,000 US dollars
- **Cost of revenue**: 10,179,000 US dollars
- **Gross profit**: 18,287,000 US dollars
- **Operating expenses (calculated)**: 16,591,000 US dollars
- **Operating income (loss)**: 1,696,000 US dollars
- **Total other income, net**: 1,057,000 US dollars
- **Income (loss) before income tax (benefit) expense**: 2,753,000 US dollars
- **Income tax (benefit) expense**: negative 42,351,000 US dollars
- **Net income (loss)**: 45,104,000 US dollars
- **Other (calculated)**: 1,707,960 US dollars
- **UNITED STATES (calculated)**: 23,057,460 US dollars
- **Europe, Middle East, Africa (EMEA) (calculated)**: 3,700,580 US dollars
- **General and administrative**: 10,694,000 US dollars
- **Research and development**: 2,958,000 US dollars
- **IPR&D expense**: 0 US dollars
- **Intangible asset amortization**: 157,000 US dollars
- **Sales and marketing**: 2,782,000 US dollars
- **Loss from discontinued operations**: 0 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.